Arterial Stiffness in Transgender Men Receiving Long-term Testosterone Therapy

被引:11
作者
Cunha, Flavia Siqueira [1 ]
Sanchez Bachega, Tania Aparecida [1 ]
Frade Costa, Elaine Maria [1 ]
Brito, Vinicius Nahime [1 ]
Alvares, Leonardo Azevedo [1 ,2 ]
Costa-Hong, Valeria Aparecida [3 ]
Sanches Verardino, Renata Gomes [3 ]
Palma Sircili, Maria Helena [1 ]
de Mendonca, Berenice Bilharinho [1 ]
Bortolotto, Luiz Aparecido [3 ]
Domenice, Sorahia [1 ]
机构
[1] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Lab Hormonios & Genet Mol LIM42,Disciplina Endocr, BR-05403900 Sao Paulo, SP, Brazil
[2] Ctr Univ Sao Camilo, Dept Endocrinol, Curso Med, BR-04264030 Sao Paulo, SP, Brazil
[3] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Unidade Hipertensao Arterial Inst Coracao InCor, BR-05403900 Sao Paulo, SP, Brazil
关键词
testosterone; female to male transsexual; transgender man; arterial stiffness; carotid-femoral pulse wave velocity; CARDIOVASCULAR RISK-FACTORS; AORTIC STIFFNESS; BLOOD-PRESSURE; SEX STEROIDS; WOMEN; HYPERTENSION; ANDROGENS; MORTALITY; ESTRADIOL; FEMALES;
D O I
10.1210/jendso/bvad040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The effects of androgen therapy on arterial function in transgender men (TM) are not fully understood, particularly concerning long-term androgen treatment. Objective: To evaluate arterial stiffness in TM receiving long-term gender-affirming hormone therapy by carotid-femoral pulse wave velocity (cf-PWV). Methods: A cross-sectional case-control study at the Gender Dysphoria Unit of the Division of Endocrinology, HC-FMUSP, Sao Paulo, Brazil. Thirty-three TM receiving intramuscular testosterone esters as regular treatment for an average time of 14 +/- 8 years were compared with 111 healthy cisgender men and women controls matched for age and body mass index. Aortic stiffness was evaluated by cf-PWV measurements using Complior device post-testosterone therapy. The main outcome measure was aortic stiffness by cf-PWV as a cardiovascular risk marker in TM and control group. Results: The cf-PWV after long-term testosterone therapy was significantly higher in TM (7.4 +/- 0.9 m/s; range 5.8-8.9 m/s) than in cisgender men (6.6 +/- 1.0 m/s; range 3.8-9.0 m/s, P <.01) and cisgender women controls (6.9 +/-.9 m/s; range 4.8-9.1 m/s, P =.02). The cf-PWV was significantly and positively correlated with age. Analysis using blood pressure as a covariate showed a significant relationship between TM systolic blood pressure (SBP) and cf-PWV in relation to cisgender women but not to cisgender men. Age, SBP, and diagnosis of hypertension were independently associated with cf-PWV in the TM group. Conclusion: The TM group on long-term treatment with testosterone had higher aging-related aortic stiffening than the control groups. These findings indicate that aortic stiffness might be accelerated in the TM group receiving gender-affirming hormone treatment, and suggest a potential deleterious effect of testosterone on arterial function. Preventive measures in TM individuals receiving testosterone treatment, who are at higher risk for cardiovascular events, are highly recommended.
引用
收藏
页数:7
相关论文
共 48 条
[1]   Gender differences in large artery stiffness pre- and post puberty [J].
Ahimastos, AA ;
Formosa, M ;
Dart, AM ;
Kingwell, BA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5375-5380
[2]   Longitudinal Trajectories of Arterial Stiffness and the Role of Blood Pressure The Baltimore Longitudinal Study of Aging [J].
AlGhatrif, Majd ;
Strait, James B. ;
Morrell, Chris H. ;
Canepa, Marco ;
Wright, Jeanette ;
Elango, Palchamy ;
Scuteri, Angelo ;
Najjar, Samer S. ;
Ferrucci, Luigi ;
Lakatta, Edward G. .
HYPERTENSION, 2013, 62 (05) :934-941
[3]   Cardiovascular Disease Risk Factors and Myocardial Infarction in the Transgender Population [J].
Alzahrani, Talal ;
Tran Nguyen ;
Ryan, Angela ;
Dwairy, Ahmad ;
McCaffrey, James ;
Yunus, Raza ;
Forgione, Joseph ;
Krepp, Joseph ;
Nagy, Christian ;
Mazhari, Ramesh ;
Reiner, Jonathan .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2019, 12 (04)
[4]   A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones [J].
Asscheman, Henk ;
Giltay, Erik J. ;
Megens, Jos A. J. ;
de Ronde, W. ;
van Trotsenburg, Michael A. A. ;
Gooren, Louis J. G. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (04) :635-642
[5]   Improvement of the lipid profile in post menopausal women who use estradiol and testosterone implants [J].
Britto, Renata ;
Araujo, Leila ;
Barbosa, Ione ;
Silva, Lidia .
GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (10) :767-769
[6]   Dissociation of Aortic Pulse Wave Velocity With Risk Factors for Cardiovascular Disease Other Than Hypertension A Systematic Review [J].
Cecelja, Marina ;
Chowienczyk, Philip .
HYPERTENSION, 2009, 54 (06) :1328-U103
[7]   Testosterone in women-the clinical significance [J].
Davis, Susan R. ;
Wahlin-Jacobsen, Sarah .
LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (12) :980-992
[8]   Androgen levels in adult females: Changes with age, menopause, and oophorectomy [J].
Davison, SL ;
Bell, R ;
Donath, S ;
Montalto, JG ;
Davis, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) :3847-3853
[9]   Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling [J].
Drager, Luciano F. ;
Bortolotto, Luiz A. ;
Figueiredo, Adelaide C. ;
Silva, Bruno Caldin ;
Krieger, Eduardo M. ;
Lorenzi, Geraldo, Jr. .
CHEST, 2007, 131 (05) :1379-1386
[10]   Cardiovascular implications of gender-affirming hormone treatment in the transgender population [J].
Dutra, Erika ;
Lee, Julie ;
Torbati, Tina ;
Garcia, Maurice ;
Merz, C. Noel Bairey ;
Shufelt, Chrisandra .
MATURITAS, 2019, 129 :45-49